The Pfizer and Modern COVID vaccines currently available in the US are being announced as the best way to control the pandemic, but the virus will continue to spread until herd immunity is reached, meaning thousands more people will get sick become – or even die. Fortunately, new research suggests that a common medication may be effective in causing the disease to progress or become fatal. Read on to find out what the new research says, and if you’m worried about being exposed to the virus. If you have these 4 new symptoms, you probably have COVID.
According to a study from February 2021 published in The BMJ, patients who get blood thinners within a day of being admitted to COVID in a hospital are more likely to survive than those who are not. Among a sample of 4,297 COVID patients with a mean age of 68 years, those who were within 24 hours of being admitted to hospital with blood thinner had a 34 percent reduced relative risk of dying from COVID compared to individuals which are not anticoagulants provided.
Blood clots are a common – and often fatal – occurrence in COVID patients; according to a review of the research published in the January 2021 journal Medical hypotheses, about one-third of severe COVID patients who have blood clotting or elevated levels of D-dimer, a protein found in the bloodstream after a clot has disintegrated.
However, blood thinners are not the only drugs that have been shown to ward off the more serious side effects of COVID; read on to discover what other medications and supplements may be the key to surviving the virus. And if you want to protect yourself, the CDC says you need to do these 3 things with your mask right now.
Read the original article Best life.
In February, researchers at the University of Oxford discovered that tocilizumab, an anti-inflammatory drug commonly prescribed to individuals with rheumatoid arthritis, could lower COVID mortality. In the review of research from the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial, researchers found that COVID patients administered tocilizumab had a mortality rate of 29 percent in the first 28 days of treatment compared to a mortality rate of 33 percent among patients who prescribed the drug. And for the latest COVID guidance, says dr. Fauci this is when you need to wear a mask after the pandemic.
Flushing your nose with a particular type of nasal spray may make you less susceptible to COVID, according to a new study. According to a preview of an in vitro study published by bioRxivXclear Sinus Care nasal spray significantly reduced the amount of virus in a test sample. Researchers claim that this is due to the combination of grapefruit seed extract (GSE) and xylitol, a non-calorie sweetener, used in the spray formula.
“GSE significantly reduces viral load while xylitol prevents virus attachment to the nuclear protein at the cell wall,” the study’s authors explained. And if you would like to protect against COVID, you can get a COVID vaccine from Rite Aid if you live in these states.
Omega-3 fatty acids have emerged, according to a new study, as a surprising way to reduce severe COVID symptoms. According to research from January 2021 published in medRxiv, individuals with the highest levels of omega-3 fatty acids in their blood have a 75 percent lower risk of COVID death compared to those with a lower circulation of omega-3 levels. This strongly suggests that these nutritionally available marine fatty acids may help reduce the risk of adverse outcomes in COVID-19 patients. Arash Asher, Managing Director, the lead author of the study. And for the latest COVID news delivered straight to your inbox, sign up for our daily newsletter.
Melatonin, a popular sleep aid, can help people get COVID, according to a recent study. A November 2020 study led by researchers at the Cleveland Clinic found that subjects who used melatonin were 30 percent less likely to develop COVID than those who did not use the supplement. However, this does not mean that you have to go out and grab a bottle for yourself. “It is very important to note that these findings do not indicate that people should start taking melatonin without consulting their doctor,” said the lead author of the study. Feixiong Cheng, PhD, assistant staff at the Genomic Medicine Institute at Cleveland Clinic.